Azadirachta indica modulates carcinogen biotransformation and reduced glutathione at peri-initiation phase of benzo(a)pyrene induced murine forestomach tumorigenesis

Phytotherapy Research

Volumn 22, Issue 9, 2008, Pages 1229-1238

  Gangar, Subhash Chander ^a   Koul, Ashwani ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Azadirachta indica; Carcinogen biotransformation enzymes; Chemoprevention; Forestomach; Liver; Reduced glutathione

Indexed keywords

AZADIRACHTA INDICA EXTRACT; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME B5; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZADIRACHTA INDICA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIVER; MOUSE; NONHUMAN; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANIMALS; AZADIRACHTA; BENZO(A)PYRENE; BIOTRANSFORMATION; CARCINOGENS; ENZYMES; FEMALE; GLUTATHIONE; MICE; MICE, INBRED BALB C; STOMACH NEOPLASMS;

AZADIRACHTA INDICA; MURINAE; MUS;

EID: 52649128348     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2453     Document Type: Article

References (52)

1. Abraham SK, Singh SP. 1999. Anti-genotoxicity and glutathioneS- transferase activity in mice pretreated with caffeinated and decaffeinated coffee. Food Chem Toxicol 37: 733-739.
2. Arivazhagan S, Velmurugan B, Bhuvaneswari V, Nagini S. 2004. Effect of aqueous extracts of garlic (Allium sativum) and neem (Azadirachta indica) leaf on hepatic and blood oxidant-antioxidant status during experimental gastric carcinogenesis. J Med Food 7: 334-339.
3. Aziz MH, Kumar R, Ahmad N. 2003. Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underling mechanisms. Int J Oncol 23: 17-28.
4. Balasenthil S, Arivazhagan S, Ramachandran CR, Ramachandran V, Nagini S. 1999. Chemopreventive potential of neem (Azadirachta indica) on 7,12-dimethylbenz(a)anthracene (DMBA) induced hamster buccal pouch carcinogenesis. J Ethnopharmacol 67: 189-195.
5. Bharali R, Tabassum J, Azad MRH. 2004. Chemomodulatory effect of Moringa oleifera, Lam, on hepatic carcinogen metabolising enzymes, antioxidant parameters and skin papillomagenesis in mice. Asian Pacific J Cancer Prev 4: 131-139.
6. Burke MD, Vadi H, Jernstrom B, Orrenius S. 1977. Metabolism of benzo(a)pyrene with isolated hepatocytes and the formation and degradation of DNA-binding derivatives. J Biol Chem 252: 6424-6431.
7. Coles P, Ketterer B. 1990. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25: 47-50.
8. Collins JF, Brown JP, Alexeeff GV, Salmon AG. 1998. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul Toxicol Pharmacol 28: 45-54.
9. Connely JC, Bridges JW. 1982. The distribution and role of cytochrome P450 in extra-hepatic organs. In Progress in Drug Metabolism, Bridges JW, Chasseaud IF (eds). Wiley: Chichester, 1-112.
10. Dasgupta T, Banerjee S, Yadava PK, Rao AR. 2004. Chemopreventive potential of Azadirachta indica (Neem) leaf extract in murine carcinogenesis model systems. J Ethnopharmacol 92: 23-36.
11. Dasgupta T, Rao AR, Yadava PK. 2003. Modulatory effect of henna leaf (Lawsonia inermis) on drug metabolising phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice. Mol Cell Biochem 245: 11-22.
12. Dipple A. 1985. Polycyclic hydrocarbons and carcinogenesis. In Polycyclic Aromatic Hydrocarbon in Carcinogenesis: An Introduction, Harvey RG (ed.). ACS Symposium Series 283, Washington, DC, 1-17.
13. Dutton GJ. 1980. In Glucuronidation of Drugs and Other Compounds, Dutton GJ (ed.). CRC: Florida, 69-78.
14. Gangar SC, Koul A. 2007. Azadirachta indica leaf extract modulates initiation phase of murine forestomach tumorigenesis. Indian J Biochem Biophys 44: 209-215.
15. Gangar SC, Sandhir R, Rai DV, Koul A. 2006a. Modulatory effects of Azadirachta indica on benzo(a)pyrene induced forestomach tumorigenesis in Balb/c mice. World J Gastroenterol 12: 2749-2755.
16. Gangar SC, Sandhir R, Rai DV, Koul A. 2006b. Preventive effects of Azadirachta indica on benzo(a)pyrene-DNA adduct formation in murine forestomach and hepatic tissues. Phytother Res 20: 889-895.
17. Gelboin HV. 1980. Benzo(a)pyrene metabolism, activation, and carcinogenesis, role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60: 1107-1166.
18. Gorski JP, Kasper CB. 1977. Purification and properties of microsomal UDP-glucuranosyltransferase from rat liver. J Biol Chem 252: 1336-1343.
19. Guengerich FP. 1991. Reactions and significance of cytochrome P-450. J Biol Chem 226: 10019-10022.
20. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione-S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
21. Hu X, Singh SV. 1997. Glutathione-S-transferases of female A/J mouse lung and their induction by anti-carcinogenic organosulfides from garlic. Arch Biochem Biophys 340: 279-286.
22. Jagetia GC, Baliga MS, Venkatesh P. 2003. Effect of Sapthaparna (Alstonia scholaris Linn) in modulating the benzo(a)pyrene induced forestomach carcinogenesis in mice. Toxicol Lett 144: 183-193.
23. Kidd PM. 1997. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1: 155-176.
24. Koul A, Ghara AR, Gangar SC. 2006a. Chemomodulatory effects of Azadirachta indica on the hepatic status of skin tumor bearing mice. Phytother Res 20: 169-177.
25. Koul A, Mukherjee N, Gangar SC. 2006b. Inhibition of DMBA-induced skin carcinogenesis by aqueous Azadirachta indica leaf extract in Balb/c mice. Mol Cell Biochem 283: 47-55.
26. Lampe WJ, King Bl, Li S et al. 2000. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 21: 1157-1162.
27. Lowry OH, Rosebrough NJ, Farr AN, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275.
28. Lu SC. 1999. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 13: 1169-1183.
29. Monro JA. 2003. Treatment of cancer with mushroom products. Arch Environ Health 58: 533-537.
30. Monteith DK, Michalopoulos G, Strom SC. 1990. Conjugation of chemical carcinogens by primary cultures of human hepatocytes. Xenobiotica 20: 753-763.
31. Moran EM. 2002. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J Environ Pathol Toxicol Oncol 21: 193-201.
32. Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67-78.
33. Nakamura Y, Ohigashi H, Masuda S et al. 2000. Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates. Cancer Res 60: 219-225.
34. Nebert DW, Gelboin HW. 1968. Substrate inducible microsomal arylhydroxylase in mammalian cell culture I. Assay and properties of induced enzyme. J Biol Chem 243: 6242-6249.
35. Omura J, Sato R. 1964a. The carbon mono-oxide binding pigment of liver microsomes. I Evidence for its haemoprotein nature. J Biol Chem 239: 2370-2378.
36. Omura J, Sato R. 1964b. The carbon mono-oxide binding pigment of liver microsomes. II Solubilisation purification and properties. J Biol Chem 239: 2379-2385.
37. 5 in cytochrome P450 reactions. J Biochem Mol Toxicol 16: 311-316.
38. Prochaska HJ, Fernandes CL. 1993. Elevation of serum phase-ll enzymes by anti-carcinogenic enzyme inducers: markers for a chemoprotected state? J Carcinog 14: 2441-2445.
39. Ray SD, Parikh H, Hickey E, Bagchi M, Bagchi D. 2001. Differential effects of IH636 grape seed proanthocyanidin extract and a DNA repair modulator 4-aminobenzamide on liver microsomal cytochrome 4502E1-dependent aniline hydroxylation. Mol Cell Biochem 218: 27-33.
40. Schoket B, Papp G, Levay K, Mrackova G, Kadlubar FF. 2001. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res 482: 57-69.
41. Sheweita SA. 2000. Drug-metabolizing enzymes: mechanisms and functions. A review. Curr Drug Metab 1: 107-132.
42. Shimada T. 2006. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21: 257-276.
43. Shimada T, Fijii-Kuriyama Y. 2004. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 95: 1-6.
44. Singh RP, Padmavathi B, Rao AR. 2000. Modulatory influence of Adhatoda vesica (Justicia adhatoda) leaf extract on the enzymes of xenobiotic metabolism, antioxidant status and lipid peroxidation in mice. Mol Cell Biochem 213: 99-109.
45. Subapriya R, Bhuvaneswari V, Nagini S. 2005. Ethanolic neem (Azadirachta indica) leaf extract induces apoptosis in the hamster buccal pouch carcinogenesis model by modulation f Bcl-2, Bim, caspase 8 and caspase 3. Asian Pac J Cancer Prev 6: 515-520.
46. Subapriya R, Nagini S. 2005. Medicinal properties of neem leaves: a review. Curr Med Chem Anti-Cancer Agents 5: 149-156.
47. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y. 1995. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82-83: 173-179.
48. Waldman JM, Lioy PJ, Greenberg A, Butler JP. 1991. Analysis of human exposure to benzo(a)pyrene via inhalation and food ingestion in the Total Human Environmental Exposure Study (THEES). J Expo Anal Environ Epidemiol 1: 193-225.
49. Wattenberg LW. 1997. An overview of chemoprevention: current status and future prospects. Proc Soc Exp Biol Med 216: 133-141.
50. Wattenberg LW, Coccia JB, Lam LK. 1980. Inhibitory effects of phenolic compounds on benzo(a)pyrene induced neoplasia. Cancer Res 40: 2820-2823.
51. Wilkinson J, Clapper M. 1997. Detoxification enzymes and chemoprevention. Proc Soc Exp Biol Med 216: 192-200.
52. Yoshimasa N, Hajime 0, Seiji MA et al. 2000. Redox regulation of glutathione-S-transferase induction by benzyl-isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates. Cancer Res 60: 219-225.